Institutional investors hold a majority ownership of CELG through the 80.53% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2017, these large investors purchased a net $4.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 2.1 Million shares of Celgene
BMO ASSET MANAGEMENT CORP. Bought 1.9 Million shares of Celgene
INVESTEC ASSET MANAGEMENT LTD. Bought 1.6 Million shares of Celgene